278 related articles for article (PubMed ID: 32623402)
1. Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial.
Xiao J; Katsumata N; Bernier F; Ohno K; Yamauchi Y; Odamaki T; Yoshikawa K; Ito K; Kaneko T
J Alzheimers Dis; 2020; 77(1):139-147. PubMed ID: 32623402
[TBL] [Abstract][Full Text] [Related]
2. Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Asaoka D; Xiao J; Takeda T; Yanagisawa N; Yamazaki T; Matsubara Y; Sugiyama H; Endo N; Higa M; Kasanuki K; Ichimiya Y; Koido S; Ohno K; Bernier F; Katsumata N; Nagahara A; Arai H; Ohkusa T; Sato N
J Alzheimers Dis; 2022; 88(1):75-95. PubMed ID: 35570493
[TBL] [Abstract][Full Text] [Related]
3. Effects of
Kobayashi Y; Kuhara T; Oki M; Xiao JZ
Benef Microbes; 2019 May; 10(5):511-520. PubMed ID: 31090457
[TBL] [Abstract][Full Text] [Related]
4. Association of Plasma Hemoglobin A1c with Improvement of Cognitive Functions by Probiotic Bifidobacterium breve Supplementation in Healthy Adults with Mild Cognitive Impairment.
Bernier F; Ohno K; Katsumata N; Shimizu T; Xiao J
J Alzheimers Dis; 2021; 81(2):493-497. PubMed ID: 33814441
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacterium Breve A1 Supplementation Improved Cognitive Decline in Older Adults with Mild Cognitive Impairment: An Open-Label, Single-Arm Study.
Kobayashi Y; Kinoshita T; Matsumoto A; Yoshino K; Saito I; Xiao JZ
J Prev Alzheimers Dis; 2019; 6(1):70-75. PubMed ID: 30569089
[TBL] [Abstract][Full Text] [Related]
6. Probiotic
Shi S; Zhang Q; Sang Y; Ge S; Wang Q; Wang R; He J
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615708
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.
Costeloe K; Bowler U; Brocklehurst P; Hardy P; Heal P; Juszczak E; King A; Panton N; Stacey F; Whiley A; Wilks M; Millar MR
Health Technol Assess; 2016 Aug; 20(66):1-194. PubMed ID: 27594381
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial.
Costeloe K; Hardy P; Juszczak E; Wilks M; Millar MR;
Lancet; 2016 Feb; 387(10019):649-660. PubMed ID: 26628328
[TBL] [Abstract][Full Text] [Related]
9. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
[TBL] [Abstract][Full Text] [Related]
10. Effects of
Sato S; Arai S; Kato K; Yoshida K; Iwabuchi N; Sagami T; Tanaka M
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542727
[TBL] [Abstract][Full Text] [Related]
11. Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial.
Solito A; Bozzi Cionci N; Calgaro M; Caputo M; Vannini L; Hasballa I; Archero F; Giglione E; Ricotti R; Walker GE; Petri A; Agosti E; Bellomo G; Aimaretti G; Bona G; Bellone S; Amoruso A; Pane M; Di Gioia D; Vitulo N; Prodam F
Clin Nutr; 2021 Jul; 40(7):4585-4594. PubMed ID: 34229263
[TBL] [Abstract][Full Text] [Related]
12. The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with
Drago L; Cioffi L; Giuliano M; Pane M; Amoruso A; Schiavetti I; Reid G; Ciprandi G; Propam Study Group
J Immunol Res; 2022; 2022():3837418. PubMed ID: 35083341
[TBL] [Abstract][Full Text] [Related]
13. Probiotic
Abdelhamid M; Zhou C; Jung CG; Michikawa M
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745273
[TBL] [Abstract][Full Text] [Related]
14. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.
Eskesen D; Jespersen L; Michelsen B; Whorwell PJ; Müller-Lissner S; Morberg CM
Br J Nutr; 2015 Nov; 114(10):1638-46. PubMed ID: 26382580
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.
Baker LD; Barsness SM; Borson S; Merriam GR; Friedman SD; Craft S; Vitiello MV
Arch Neurol; 2012 Nov; 69(11):1420-9. PubMed ID: 22869065
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects.
Inoue T; Kobayashi Y; Mori N; Sakagawa M; Xiao JZ; Moritani T; Sakane N; Nagai N
Benef Microbes; 2018 Dec; 9(6):843-853. PubMed ID: 30198326
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial.
Maldonado J; Gil-Campos M; Maldonado-Lobón JA; Benavides MR; Flores-Rojas K; Jaldo R; Jiménez Del Barco I; Bolívar V; Valero AD; Prados E; Peñalver I; Olivares M
BMC Pediatr; 2019 Oct; 19(1):361. PubMed ID: 31630683
[TBL] [Abstract][Full Text] [Related]
18. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
Patole S; Keil AD; Chang A; Nathan E; Doherty D; Simmer K; Esvaran M; Conway P
PLoS One; 2014; 9(3):e89511. PubMed ID: 24594833
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.
Shin HY; Kim HR; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
BMC Complement Med Ther; 2021 Oct; 21(1):251. PubMed ID: 34620151
[TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.
Tursi A; Brandimarte G; Papa A; Giglio A; Elisei W; Giorgetti GM; Forti G; Morini S; Hassan C; Pistoia MA; Modeo ME; Rodino' S; D'Amico T; Sebkova L; Sacca' N; Di Giulio E; Luzza F; Imeneo M; Larussa T; Di Rosa S; Annese V; Danese S; Gasbarrini A
Am J Gastroenterol; 2010 Oct; 105(10):2218-27. PubMed ID: 20517305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
